A comparative analysis of core needle biopsy and final excision for breast cancer: Histology and marker expression

American Journal of Surgery

Volumn 201, Issue 5, 2011, Pages 692-694

  Ough, Matthew ^a,b   Velasco, Jose ^a,b,c   Hieken, Tina J ^a,b,c  

^a North Shore University Health System   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

Breast cancer; Core needle biopsy; Her 2 neu; Histology; p53; Tumor markers

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CORE NEEDLE BIOPSY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; MITOSIS RATE; NEEDLE BIOPSY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79955679337     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.02.015     Document Type: Article

References (11)

1. Litherland JC, Evans AJ, Wilson ARM, et al. The impact of corebiopsy on pre-operative diagnosis rate of screen detected breast cancers. Clin Radiol 1996;51:562-5.
2. Nathanson SD, Slater R, Debruyn D, et al. HER-2/neu expression in primary breast cancer with sentinel lymph node metastasis. Ann Surg Oncol 2006;13:205-13. (Pubitemid 43157415)
3. Chapgar AB, McMasters KM, Edwards MJ. Can sentinel node biopsy be avoided in some elderly breast cancer patients? Ann Surg 2009; 249:455-60.
4. Crowe JP, Patrick RJ, Rybicki LA, et al. Does ultrasound core breast biopsy predict histologic finding on excisional biopsy? Am J Surg 2003;186:397-9.
5. Rakha EA, Ellis IO. An overview of assessment of prognostic and predictive factors in breast cancer needle biopsy specimens. J Clin Pathol 2007;60:1300-6. (Pubitemid 350247244)
6. McGinn T, Wyer PC, Newman TB, et al. Tips for learners of evidence-based medicine: measures of observer variability (kappa statistic). CMAJ 2004;171:1369-73. (Pubitemid 39573841)
7. Huo L, Sneige N, Hunt KK, et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendation for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 2006;107:1759-68.
8. Harris GC, Denley HE, Pinder SE, et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol 2003;27:11-5. (Pubitemid 36014894)
9. Park SY, Kim KS, Lee T-G, et al. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer. Am J Surg 2009;197:266-9.
10. Richter-Ehrenstein C, Muller S, Noske A, et al. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients. Int J Pathol 2009;17:323-6.
11. Cavaliere A, Sidoni A, Scheibel M, et al. Biopathologic profile of breast cancer core biopsy: is it always a valid method? Cancer Lett 2005;218:117-21.